Akèy › Poliradikiloneyropati demyelinizan enflamatwa kwonik › Alabama › Birmingham
Etid klinik pou Poliradikiloneyropati demyelinizan enflamatwa kwonik nan Birmingham, AL
4 etid pou Poliradikiloneyropati demyelinizan enflamatwa kwonik ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Ap rekriteFaz 3
- University of Alabama at Birmingham - 1720 University Blvd, Birmingham
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Ap rekriteFaz 3
- University of Alabama, Birmingham
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Ap rekriteFaz 3
- Alabama Neurology Associates- Site Number : 8400019, Homewood · 3 mi lwen
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Ap rekriteFaz 3
- Clinical Study Site, Birmingham
Etid Poliradikiloneyropati demyelinizan enflamatwa kwonik nan lòt vil
- New York City, NY7 etid
- Miami, FL6 etid
- Houston, TX6 etid
- Kansas City, KS5 etid
- Indio, CA5 etid
- Philadelphia, PA5 etid
- New Haven, CT5 etid
- St. Louis, MO5 etid
- Tampa, FL4 etid
- Cleveland, OH4 etid
- Milwaukee, WI4 etid
- Washington, DC4 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Obèsite23 etid
- Kansè ovè23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Sipwa16 etid
- Kansè Endomèt16 etid
- Dyabèt Tip 216 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.